Using heart rate variability as a potential biomarker for diagnostic support and early screening of schizophrenia and bipolar disorder could eventually lead to faster, less costly assessments outside ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

New research uncovers how cancer-induced nerve injury drives resistance to anti-PD-1 therapy, revealing potential strategies to enhance treatment efficacy.

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

The NIH is funding a new study at Weill Cornell that aims to identify the regulatory roles of gene variants involved in Type ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Jennifer Walsh of George Washington University’s School of Nursing warned that limiting COVID-19 vaccine approvals to older ...

Previous research has shown the recombinant zoster vaccine is more effective than its live-attenuated predecessor, but new ...

Illuminate Rx is the country’s first pharmacist-designed pharmacy benefits optimizer (PBO), offering transparent, clinically ...

Ocaliva, approved for primary biliary cholangitis, faced FDA warnings and restrictions after postmarket data showed higher ...

Diagnosed with triple-negative breast cancer at age 36 and now in remission, gynecological oncologist Deanna Gerber, M.D., says her experience has made her a better physician and advocate for her ...